| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |